Clinical TrialsSearch results
Number of results: 718
Recruiting
- Phase 3 Study to Investigate the Efficacy and Safety of Furmonertinib Compared to Platinum-Based Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer.
- Locally advanced or metastatic non-squamous non-small cell lung cancer
- Imanishi Naoki
- 2023-06-03
Recruiting
- Phase I/II study of rapcabtagene autoleucel in CLL, 3L+ DLBCL, ALL and 1L HR LBCL
- DLBCL, ALL, CLL
- Yamauchi Kyosuke
- 2022-01-31
Recruiting
- Phase II study of combination chemotherapy with S-1 plus Avastin in unresectable or recurrent colorectal cancer after failure of prior chemotherapy, including irinotecan and oxaliplatin regimens.
- colorectal cancer
- Translational Research Informatics Center(TRI)
- 2009-08-07
Recruiting
- Phase II study of modified S-1, docetaxel and cisplatin combination chemotherapy (mDCS) in patients with unresectable metastatic gastric cancer.
- Gastric cancer
- Tokushima-Hokkaido cancer therapy clinical trial group
- 2009-10-01
Recruiting
- Phase II study of prophylactic oral administration of diltiazem for atrial fibrillation after lung resection
- atrial fibrillation after lung resection
- Department of Surgical Oncology, Hokkaido University Graduate School of Medicine
- 2009-02-06
Recruiting
- Phase II trial of docetaxel/pembrolizumab in head and neck squamous cell carcinoma
- head and neck squamous cell carcinoma
- Shimizu Yasushi
- 2022-02-01
Recruiting
- Phase II trial using imatinib combined with chemotherapy for newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Japan Adult Leukemia Study Group
- 2008-07-07
Recruiting
- Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants
- resected SCCHN, who are at high risk for relapse and are ineligible for high-dose cisplatin
- Suzuki Tomoya
- 2022-08-10
Recruiting
- Phase two clinical trial of limited stage lymphoblastic lymphoma.
- Limited stage lymphoblastic lymphoma
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26
Recruiting
- Pilot study for evaluation of the effect of AHCC(R) on reducing lenvatinib-related adverse events in patients.
- hepatocellular carcinoma
- Taketomi Akinobu
- 2024-03-08